Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stockpile
Manufacturing
Lilly starts banking stockpile of oral GLP-1 asset
Eli Lilly is building commercial supply of its oral GLP-1 contender orforglipron well before the drug’s expected approval in 2026.
Fraiser Kansteiner
Feb 24, 2025 10:47am
Kindeva unit snares $129M to supply US with nerve agent antidote
Jan 22, 2025 9:18am
Lilly scores $720M deal with U.S. for latest antibody treatment
Feb 11, 2022 8:52am
BARDA taps Emergent for extra anthrax vaccine doses
Jul 14, 2020 12:12pm
Inside Novartis' fight to keep its supply chain open amid COVID
Jun 4, 2020 11:20am
U.K. tells drugmakers to stockpile in case Brexit goes bad
Aug 23, 2018 12:07pm